Medical Bulletin 17/December/2025
Here are the top medical news for today:
AIIMS study finds no evidence linking Covid vaccines to sudden deaths
Sudden deaths among young people have sparked widespread concern in recent years—but a new study from India’s premier medical institute offers much-needed clarity. A one-year autopsy-based study at the All India Institute of Medical Sciences (AIIMS), New Delhi, has found no evidence linking COVID-19 vaccination to sudden deaths in young adults, reaffirming the safety of vaccines used during the pandemic. The findings, published in the Indian Journal of Medical Research, highlight that underlying heart disease, not vaccination, remains the leading cause of unexplained deaths in younger age groups.
Sudden cardiac death (SCD) has long been a complex public health issue, often striking young, seemingly healthy individuals without warning. To investigate whether the phenomenon had any connection to COVID-19 vaccines, a team from the Departments of Pathology and Forensic Medicine and Toxicology at AIIMS conducted a cross-sectional, autopsy-based study between May 2023 and April 2024. Cases meeting the clinical definition of sudden death among adults aged 18 to 45 were included, while causes such as trauma, suicide, homicide, and drug abuse were excluded to ensure focus on medical origins.
Each case underwent extensive examination—including verbal autopsy interviews with families, post-mortem imaging, conventional autopsy, and detailed histopathological analysis. A multidisciplinary team reviewed every case to confirm causes of death and compare findings across two age groups: younger adults (18–45) and older adults (46–65).
During the study period, AIIMS forensic specialists received 2,214 cases, out of which 180 qualified as sudden deaths. Of these, 57.2% (103 cases) involved young adults. The majority were attributed to coronary artery disease (CAD), while respiratory causes like tuberculosis and pneumonia also contributed significantly. Importantly, there was no statistically significant difference in COVID 19 vaccination history or prior infection between those who died suddenly and those who did not.
Lead investigator Dr. Sudheer Arava emphasized that “scientific evidence does not support claims of a causal link between vaccines and sudden deaths.” He cautioned against misinformation, stressing that cardiovascular diseases—often undiagnosed—remain the most common trigger in these cases.
The study underscores the urgent need for better early detection and prevention strategies, such as routine cholesterol and blood pressure screening for young adults. As Dr. Arava concluded, “Citizens should rely on credible science, not speculation. Vaccines save lives—our focus must shift to heart health and lifestyle awareness to truly protect the young.”
REFERENCE: Surabhi Jain, Sudhir Gupta, Abilash Srinivasa Murthy, et al.; Burden of sudden death in young adults: A one-year observational study at a tertiary care centre in India; Indian Journal of Medical Research; 162 (4);453-459; doi:10.25259/IJMR_938_2025
Study Finds replacing high-carb snacks with tree nuts reduces cravings in at-risk youth
Could something as small as swapping your daily snack make a difference in your health? A new clinical study says yes. Researchers found that replacing high-carb snacks with a handful of mixed tree nuts can significantly improve diet quality and curb cravings—especially for sweets and junk food—among young adults at risk for metabolic syndrome. The 16 week trial, published in Nutrients, suggests that this simple snack switch could help promote better eating habits without weight gain.
Metabolic syndrome (MetS) is a cluster of risk factors—including high blood pressure, excess fat, and elevated blood sugar—that now affects nearly one in three young adults in the U.S. Because snacking habits contribute 200–300 “extra” calories a day, improving snack quality can be an easy first step toward reducing long-term cardiometabolic risk.
To test this idea, scientists recruited 84 adults aged 22–36, all with at least one MetS risk factor. After a two-week stabilization period on standardized diets, participants were randomly assigned to one of two groups for 16 weeks: a tree nut group (33.5 g of mixed almonds, walnuts, pistachios, and other nuts twice daily) or a high carbohydrate group that received matched-calorie snacks such as pretzels and graham crackers. Both diets were closely monitored for nutrient content, and participants logged food intake and craving levels using validated tools like the Food Craving Inventory and the Healthy Eating Index (HEI 2015).
The results were striking. Compared with the carb snack group, those who ate tree nuts reported significant reductions in cravings for cookies, brownies, candy, and fast food. Sweet taste preference dropped by 12.5%, while intake of protein rich foods such as seafood and legumes increased. Their HEI score rose by nearly 19%, driven by improvements in healthy fat ratios, protein quality, and reduced sodium. Meanwhile, the carb snack group gained about 0.8 kg and consumed 349 extra calories per day.
Blood analyses revealed that nut eaters had higher GLP 1 levels, a hormone that signals fullness and better appetite regulation, correlating with fewer sugar cravings.
Overall, the study shows that structured nut snacking improves food choices, diet quality, and appetite control—without restrictive dieting. For young adults struggling with cravings or weight management, this research makes one thing clear: a handful of nuts a day might just be the smartest snack swap you can make.
REFERENCE: Lillegard, K., Widmer, A., Koethe, J. R., & Silver, H. J. (2025). Consuming Tree Nuts Daily as Between-Meal Snacks Reduces Food Cravings and Improves Diet Quality in American Young Adults at High Metabolic Syndrome Risk. Nutrients, 17(23). DOI: 10.3390/nu17233778, https://www.mdpi.com/2072-6643/17/23/3778
Scientists uncover how cinnamon’s bioactive compounds influence cancer pathways
Cinnamon might be more than a kitchen spice—it could one day help fight cancer. A new review published in Frontiers in Nutrition brings together years of laboratory and animal evidence suggesting that cinnamon and its natural compounds can disrupt cancer-related processes, including inflammation, tumor growth, and the formation of new blood vessels. However, researchers caution that more human studies are needed before anyone considers cinnamon a therapeutic option.
Used for centuries in traditional medicine, cinnamon’s health effects have long been explored in the context of blood sugar regulation and metabolic health. Now, with growing interest in natural plant compounds as affordable supplements to conventional medicine, scientists are investigating whether compounds from cinnamon might also block or slow cancer development.
The review analyzed a large body of in vitro (cell-based) and animal studies exploring how cinnamon influences molecular pathways linked to cancer. The main compound, cinnamaldehyde, along with others such as caffeic acid, eugenol, and procyanidin B2, showed the strongest biological impact. These phytochemicals were found to trigger apoptosis (programmed cancer cell death), limit proliferation, and reduce metastatic ability in multiple tumor models. Modified derivatives of cinnamic acid even showed anti metastatic benefits, highlighting how small chemical changes can amplify their therapeutic potential.
Mechanistic studies revealed that cinnamon compounds can suppress key transcription factors such as NF κB and AP 1, which drive inflammation, cell survival, and angiogenesis in cancers. In mouse tumor models, cinnamon treatment reduced NF κB activity and tumor size. The team also noted that cinnamon activates Nrf2, a protective factor regulating antioxidant and detoxification genes—potentially helpful in preventing cancer initiation but possibly risky in established tumors where Nrf2 can aid survival and treatment resistance.
Moreover, cinnamon extracts appear to curb angiogenesis by dampening VEGF and HIF 1α signaling—pathways that tumors exploit to build blood vessels. Early evidence also suggests cinnamon polyphenols may favor healthier gut microbiome balance and reduce chronic inflammation, both critical for cancer prevention.
Still, experts stress that dietary doses likely fall below active therapeutic levels, and compounds like coumarin—naturally present in cinnamon—can cause liver toxicity at high concentrations. Future research must establish safe dosing, long term effects, and delivery methods to enhance bioavailability.
While the results are promising, the review concludes that cinnamon’s anti cancer promise remains preliminary. For now, the spice can be part of a healthy diet—but its medical potential awaits confirmation through rigorous clinical trials and standardized formulations.
REFERENCE: Anderson, M., Hrivnak, W., Prak, K., Stockert, A. (2025). Potential effects of cinnamon on cancer prevention and progression. Frontiers in Nutrition, 12. DOI: 10.3389/fnut.2025.1717834, https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1717834/full
Anshika Mishra is a dedicated scholar pursuing a Masters in Biotechnology, driven by a profound passion for exploring the intersection of science and healthcare. Having embarked on this academic journey with a passion to make meaningful contributions to the medical field, Anshika joined Medical Dialogues in 2023 to further delve into the realms of healthcare journalism.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.